{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:12Z","timestamp":1790744412274,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Blood transfusion is associated with potential risks of transfusion-transmitted infections (TTIs). Different strategies are needed to monitor blood safety and screen the donors\u2019 efficacy, such as evaluation of the prevalence and trends of TTIs. This study was conducted to evaluate the prevalence and trends of TTIs, including hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus (HTLV 1\/2), and the impact of the donors\u2019 characteristics such as age, sex, and donor status on the prevalence of TTIs in blood donors in seven large provinces of Iran from 2010 to 2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was conducted on the data collected from all blood donations in seven Iranian Blood Transfusion Centers including Ardabil, Alborz, Guilan, West Azarbaijan, North, Razavi, and South Khorasan from April 2010 to March 2018. Demographic characteristics, number of donations, donor status, and screening and confirmatory serological results of all blood donations were collected from Iranian Blood Transfusion Organizations (IBTO) national database. The prevalence and trend of HBV, HCV, HIV, and HTLV 1\/2 infections were reported according to the donation year and donor\u2019s characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis of the prevalence and trend of TTIs in 3,622,860 blood donors showed a significant decreasing trend in first-time and regular donors. Additionally, compared to first- time donors, regular donors made safer blood donations with lower risks of HBV, HIV, HCV and HTLV 1\/2 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001). Although the prevalence of HTLV 1\/2 and HBV was higher in females, TTIs had a significant decreasing trend in males and females. Finally, it was found that the prevalence of HBV and HTLV 1\/2 increased with age up to 40\u201349\u2009years and then decreased thereafter.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The decreasing trends of TTIs in Iranian donors during 9 years may indicate that the various strategies implemented by IBTO have been effective in recent years. Other factors such as a decrease in the prevalence of specific TTIs in the general population might have also contributed to these declines.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05405-9","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T13:03:57Z","timestamp":1602075837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety"],"prefix":"10.1186","volume":"20","author":[{"given":"Azadeh","family":"Omidkhoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Razi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Arabkhazaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Amini Kafi-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"5405_CR1","doi-asserted-by":"publisher","first-page":"6810959","DOI":"10.1155\/2019\/6810959","volume":"2019","author":"JK Makin","year":"2019","unstructured":"Makin JK, et al. Interventions to increase blood donation among ethnic\/racial minorities: a systematic review. J Environ Public Health. 2019;2019:6810959.","journal-title":"J Environ Public Health"},{"key":"5405_CR2","doi-asserted-by":"crossref","unstructured":"Ferguson E, Murray C, O'Carroll RE. Blood and organ donation: health impact, prevalence, correlates, and interventions. Psychol Health. 2019;34(9):1073-104.","DOI":"10.1080\/08870446.2019.1603385"},{"issue":"7","key":"5405_CR3","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/j.1559-1816.2001.tb02681.x","volume":"31","author":"CJ Armitage","year":"2001","unstructured":"Armitage CJ, Conner M. Social cognitive determinants of blood donation. J Appl Soc Psychol. 2001;31(7):1431\u201357.","journal-title":"J Appl Soc Psychol"},{"issue":"1","key":"5405_CR4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1423-0410.2007.00990.x","volume":"94","author":"BN Sojka","year":"2008","unstructured":"Sojka BN, Sojka P. The blood donation experience: self-reported motives and obstacles for donating blood. Vox Sang. 2008;94(1):56\u201363.","journal-title":"Vox Sang"},{"key":"5405_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JBM.S229327","volume":"10","author":"MT Soodejani","year":"2019","unstructured":"Soodejani MT, et al. The trends of viral hepatitis B and C and HIV infections in donated bloods in Iran between 2003 and 2017. J Blood Med. 2019;10:435.","journal-title":"J Blood Med"},{"key":"5405_CR6","doi-asserted-by":"crossref","unstructured":"Moghaddasifar I, et al. Prevalence of hepatitis B virus infection among pregnant women in Iran: a systematic review and Meta-analysis. Iran J Cancer Prev. 2016;9(6):e3703.","DOI":"10.17795\/ijcp-3703"},{"issue":"1","key":"5405_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-018-0231-0","volume":"15","author":"M Behzadifar","year":"2018","unstructured":"Behzadifar M, et al. Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis. Harm Reduct J. 2018;15(1):24.","journal-title":"Harm Reduct J"},{"issue":"1","key":"5405_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12985-017-0693-9","volume":"14","author":"G Karimi","year":"2017","unstructured":"Karimi G, Zadsar M, Pourfathollah AA. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Virol J. 2017;14(1):14.","journal-title":"Virol J"},{"issue":"6","key":"5405_CR9","doi-asserted-by":"publisher","first-page":"e0157615","DOI":"10.1371\/journal.pone.0157615","volume":"11","author":"F Farshadpour","year":"2016","unstructured":"Farshadpour F, et al. Prevalence and trends of transfusion-transmissible viral infections among blood donors in south of Iran: an eleven-year retrospective study. PLoS One. 2016;11(6):e0157615.","journal-title":"PLoS One"},{"issue":"08","key":"5405_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/fvl-2018-0015","volume":"13","author":"M Azami","year":"2018","unstructured":"Azami M, et al. Epidemiology of human T-lymphotropic virus type 1 among blood donors and general population in Iran: a meta-analysis. Futur Virol. 2018;13(08):585\u201399.","journal-title":"Futur Virol"},{"issue":"3","key":"5405_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00002030-199803000-00010","volume":"12","author":"AL Fontanet","year":"1998","unstructured":"Fontanet AL, et al. Age-and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. Aids. 1998;12(3):315\u201322.","journal-title":"Aids"},{"issue":"1","key":"5405_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12879-019-4044-x","volume":"19","author":"L Chang","year":"2019","unstructured":"Chang L, et al. Demographic characteristics of transfusion-transmitted infections among blood donors in China. BMC Infect Dis. 2019;19(1):514.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5405_CR13","doi-asserted-by":"publisher","first-page":"e0219709","DOI":"10.1371\/journal.pone.0219709","volume":"14","author":"C Eren","year":"2019","unstructured":"Eren C. An analysis on HBsAg, anti-HCV, anti-HIV\u00bd and VDRL test results in blood donors according to gender, age range and years. PLoS One. 2019;14(9):e0219709.","journal-title":"PLoS One"},{"issue":"10","key":"5405_CR14","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/j.1537-2995.2009.02245.x","volume":"49","author":"S Amini Kafi-abad","year":"2009","unstructured":"Amini Kafi-abad S, et al. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009;49(10):2214\u201320.","journal-title":"Transfusion"},{"issue":"4","key":"5405_CR15","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.ijid.2012.10.006","volume":"17","author":"Z-H Ji","year":"2013","unstructured":"Ji Z-H, et al. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi\u2019an, China between 1999 and 2009. Int J Infect Dis. 2013;17(4):e259\u201362.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"5405_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1423-0410.2003.00296.x","volume":"84","author":"K Soldan","year":"2003","unstructured":"Soldan K, et al. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993\u20132001. Vox Sang. 2003;84(4):274\u201386.","journal-title":"Vox Sang"},{"issue":"11","key":"5405_CR17","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/j.0041-1132.2004.04153.x","volume":"44","author":"S Zou","year":"2004","unstructured":"Zou S, et al. Patterns of age-and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American red Cross blood donor study. Transfusion. 2004;44(11):1640\u20137.","journal-title":"Transfusion"},{"issue":"9","key":"5405_CR18","first-page":"613","volume":"17","author":"F Mohammadali","year":"2014","unstructured":"Mohammadali F, Pourfathollah AA. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005\u20132011. Arch Iran Med. 2014;17(9):613\u201320.","journal-title":"Arch Iran Med"},{"issue":"10","key":"5405_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/j.1537-2995.2005.00576.x","volume":"45","author":"M Gonzalez","year":"2005","unstructured":"Gonzalez M, et al. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Transfusion. 2005;45(10):1670\u20135.","journal-title":"Transfusion"},{"issue":"10","key":"5405_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3855\/jidc.311","volume":"3","author":"AC Shrestha","year":"2009","unstructured":"Shrestha AC, et al. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal. J Infect Dev Ctries. 2009;3(10):794\u20137.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"5405_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7243\/2052-434X-2-4","volume":"2","author":"HI Nwokeukwu","year":"2014","unstructured":"Nwokeukwu HI, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis in blood donors in a tertiary health facility in south eastern Nigeria. Hematol Leukemia. 2014;2(1):4.","journal-title":"Hematol Leukemia"},{"issue":"5","key":"5405_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.19026\/ajms.5.5362","volume":"5","author":"A Adekeye","year":"2013","unstructured":"Adekeye A, et al. Prevalence of hepatitis B and C among blood donors in Jos south LGA, plateau state, Nigeria. Asian J Med Sci. 2013;5(5):101\u20134.","journal-title":"Asian J Med Sci"},{"issue":"1","key":"5405_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.transci.2015.03.003","volume":"53","author":"M Keshvari","year":"2015","unstructured":"Keshvari M, et al. Prevalence and trends of transfusion- transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus Apher Sci. 2015;53(1):38\u201347.","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"5405_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23181","volume":"84","author":"M Satake","year":"2012","unstructured":"Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84(2):327\u201335.","journal-title":"J Med Virol"},{"issue":"3","key":"5405_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172\u20136.","journal-title":"J Clin Virol"},{"issue":"5","key":"5405_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/00313020903041010","volume":"41","author":"M Tarhini","year":"2009","unstructured":"Tarhini M, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009;41(5):498\u20139.","journal-title":"Pathology"},{"issue":"39","key":"5405_CR27","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058.","journal-title":"Oncogene"},{"issue":"2","key":"5405_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3923\/ajbs.2014.35.46","volume":"7","author":"S Alizadeh","year":"2014","unstructured":"Alizadeh S, et al. Prevalence of hepatitis B among blood donors in Iran: a systematic review and meta-analysis. Asian J Biol Sci. 2014;7(2):35\u201346.","journal-title":"Asian J Biol Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05405-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05405-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05405-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:29:48Z","timestamp":1698229788000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05405-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5405"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05405-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In IBTO, each donor has to sign a <i>consent<\/i> before <i>donation. Based on these forms, donors<\/i> permit the IBTO to store their information in the blood donor database. This study used the data stored in this national database. The protocol of the study was approved by the Research Committee of High Institute for Research and Education in Transfusion Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"736"}}